Halyna Makukh

Halyna Makukh

Auto-generated profile, based on publicly available information

Halyna Makukh

Ivan Franko National University of Lviv 4 Hrushevsky St. 79005 Lviv Ukraine

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2022 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
PDPavel Drevinek
Pavel Drevinek
KSKatarina Stepankova
Katarina Stepankova
ŁWŁukasz Woźniacki
Łukasz Woźniacki
AHAdrien Halasz
Adrien Halasz
GPGuergana Petrova
Guergana Petrova
DSDorota Sands
Dorota Sands

1 March 2025 in Studia Biologica
Verified
Journal Article
Open access
PDF file
VKVolodymyr Kravets
Volodymyr Kravets
ISIvanna Shymanska
Ivanna Shymanska
OBOksana Boyarchuk
Oksana Boyarchuk
NMNataliya Matiytsiv
Nataliya Matiytsiv
OAOksana Arkhipova
Oksana Arkhipova
HMHalyna Makukh
Halyna Makukh
Background. Primary immunodeficiency (PID) compromise the immune system, leaving newborns highly vulnerable to infections. Severe combined immunodeficiency (SCID) is the most severe form, characterized by the absence or dysfunction of T and B cells. Without early treatment, most infants with SCID do not survive their first year. In Ukraine, after a successful pilot project, newborn screening for SCID and other types of PID is now part of Advanced Neonatal Screening, using T-cell receptor excision circles (TREC) and kappa-deleting recombination excision circles (KREC) measurements. Since the pilot project used a different method than the current screening program, the purpose of this study was to compare these two methods, evaluating their benefits and downsides, aiming to optimize screening for early, effective treatment. Materials and Methods. In the pilot project method (Method 1), TREC and KREC quantification was performed using a custom real-time PCR assay with melting curve analysis. Method 1 included standards with known TREC and KREC copy numbers, no-template controls (NTCs), and positive controls to ensure reliable results. The method currently employed in the Advanced Neonatal Screening (Method 2) uses the Biocore® SMA/TKID PLUS Diagnostic Kit, a commercial kit, for TREC, KREC and SMN1 quantification via real-time PCR. Measurements for both methods are reported per one million cells. Results and Discussion. While there are differences in the general parameters of DNA extraction, PCR, and result analysis and interpretation, both Method 1 and Method 2 showed a significant difference in Cq values. Despite these differences, both methods demonstrated the capability of inentifying abnormal TREC/KREC values, enabling the detection of SCID and some PID cases. Conclusion. The pilot project demonstrated the effectiveness of TREC/KREC quantification for SCID screening and led to its implementation in Advanced Neonatal Screening in Ukraine. Over 121,000 newborns were tested, confirming six positive cases. Method 1 provides higher precision and versatility, while Method 2 is faster, simpler, and capable of automation but lacks precise quantification. Adding standards to Method 2 could enhance its utility for widespread SCID screening.

28 April 2024 in Modern pediatrics. Ukraine
Verified
Journal Article
Open access
PDF file
OBOksana Boyarchuk
Oksana Boyarchuk
OCO.B. Chubata
O.B. Chubata
OSO.Ye. Smashna
O.Ye. Smashna
HMH.V. Makukh
H.V. Makukh
UHUkraine Ternopil Regional Children'S Clinical Hospital
Ukraine Ternopil Regional Children'S Clinical Hospital
MSMunicipal Non-Profit Enterprise Lviv Regional Clinical Perinatal Center Regional Center Of Neonatal Screening
Municipal Non-Profit Enterprise Lviv Regional Clinical Perinatal Center Regional Center Of Neonatal Screening
Coffin-Siris syndrome encompasses a group of genetic disorders with a wide spectrum of phenotypic features, characterized by varying degrees of intellectual disability, developmental delay, and other clinical signs. Among the most common features are the aplasia or hypoplasia of the distal phalanx or nail of the fifth finger and coarse facial features. The aim of the work is to increase awareness among physicians about the diagnosis of Coffin-Siris syndrome and expand knowledge of the spectrum of clinical features of the disease based on the presentation of two clinical cases. We presented two clinical cases of Coffin-Siris syndrome caused by variants in the SMARCA4 and DPF2 genes. In both cases, there is a delay in speech development, cognitive impairments of varying severity, behavioral changes, characteristic dysmorphic features, and changes in the hands and/or feet, especially in the little finger. Distal phalanx nail hypoplasia of the fifth finger was present in the case associated with a variant in the DPF2 gene. In the patient with a variant in the SMARCA4 gene, flexion deformity of the little finger and broad palms were observed. Pachydermodactyly and a congenital kidney defect were also diagnosed in this patient. Thus, genetic diagnosis allows for timely identification, preventing complications and avoiding unnecessary investigations. Accumulating clinical data on rare diseases and their systematization contribute to research development and, subsequently, to determining optimal therapeutic approaches. The identified genetic factor in the proband ensures genetic counseling for the family and determining risk indicators for pathologies in offspring. The research was carried out in accordance with the principles of the Helsinki Declaration. The informed consent of the patient was obtained for conducting the studies. No conflict of interests was declared by the authors.

31 March 2022 in EUREKA: Life Sciences
Verified
Journal Article
Open access
PDF file
ISIvanna Shymanska
Ivanna Shymanska
ОTОlena Trutiak
Оlena Trutiak
ОLОlena Lychkovska
Оlena Lychkovska
HMHalyna Makukh
Halyna Makukh
OAOvanes Akopyan
Ovanes Akopyan
According to world publications, mutations in the SERPINA1 gene may be a genetic risk factor for severe chronic obstructive pulmonary disease and, consequently, rapid progression of respiratory dysfunction. This disease leads to a decrease in the level of alpha-1-antitrypsin protein. It is inherited by autosomal recessive type, but there are registered cases of codominance. In the absence of treatment, diseases of the respiratory system become chronic and lead to disability in adulthood. Early diagnosis of AAT deficiency is important to prevent complications and reduce mortality among people with this pathology. Due to these factors, genetic testing of SERPINA1 gene mutations in children with chronic lung diseases is appropriate to detect and prevent severe complications, associated with AATD. The aim of this work is to improve the effectiveness of early diagnosis of AAT deficiency in children with bronchial asthma and recurrent obstructive bronchitis by identifying different genotypes and phenotypes of A1AT deficiency, studying their relationship with the clinical course of respiratory diseases in children

10 January 2021 in Open Access Macedonian Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
OFOlena Fedota
Olena Fedota
ISIurii Sadovnychenko
Iurii Sadovnychenko
LCLilia Chorna
Lilia Chorna
LRLarysa Roshcheniuk
Larysa Roshcheniuk
VVVitalii Vorontsov
Vitalii Vorontsov
HMHalyna Makukh
Halyna Makukh
BACKGROUND: Ichthyosis vulgaris is the most common type of Mendelian disorders of cornification, caused by loss-of-function mutations in the gene encoding epidermal protein filaggrin (FLG), namely R501X and 2282del4. FLG 2282del4 mutation in heterozygotes is incompletely penetrant. Polymorphisms in one-carbon metabolism genes could be associated with clinical manifestation of ichthyosis vulgaris. AIM: The purpose of the present study was to analyze the effects of MTHFR, MTR and MTRR polymorphisms in patients with ichthyosis vulgaris. METHODS: 31 patients with ichthyosis vulgaris, 7 their FLG heterozygous relatives without symptoms of disorder, and 150 healthy controls were enrolled in study. FLG null mutations —R501X (rs61816761) and 2282del4 (rs558269137) — and one-carbon metabolism gene polymorphisms — MTHFR C677T (rs1801133), MTHFR A1298C (rs1801131), MTR A2756G (rs1805087) and MTRR A66G (rs1801394) — were analyzed by a polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) assay. RESULTS: Among patients with ichthyosis, heterozygous for FLG 2282del4 mutation, the distributions of genotypes for folate metabolism genes were: MTHFR C677T CC:CT:TT —29.4%:70.6%:0.0%; MTHFR A1298C AA:AC:CC — 52.9%:47.1%:0.0%; MTR A2756G AA:AG:GG — 70.3%:23.5%:5.9%; MTRR A66G AA:AG:GG — 23.4%:52.9%:23.5%. The frequencies of MTR 2756AA and MTRR 66GG genotypes were 1.4–1.6 times higher in affected individuals heterozygous for 2282del4 than in patients with other FLG genotypes. In affected 2282del4 heterozygotes, the frequency of MTR 2756AA genotype was 1.6 times greater than in healthy controls (p<0.01). The strongest association was found between MTHFR 677CT/MTHFR 1298AA/MTR 2756AA/MTRR 66AG genotype and ichthyosis — OR=11.23 (95% CI 2.51−50.21, p=0.002). CONCLUSIONS: Various genotypes of one-carbon metabolism genes increase the risk of ichthyosis in heterozygotes for the FLG 2282del4 mutation (OR 2.799‑11.231). The most probable predisposing genotype is 677CT/1298AA/2756AA+AG/66AG.

29 November 2022 in Modern pediatrics. Ukraine
Verified
Journal Article
Closed access
LCLviv Сne Of Lrc «Western Ukrainian Specialized Pediatric Medical Centre»
Lviv Сne Of Lrc «Western Ukrainian Specialized Pediatric Medical Centre»
ODO.I. Dorosh
O.I. Dorosh
KBKh.I. Bodak
Kh.I. Bodak
HMH.W. Makukh
H.W. Makukh
ITI.P. Tsymbalyuk-Voloshyn
I.P. Tsymbalyuk-Voloshyn
LSL.P. Seredych
L.P. Seredych
Erythropoietic protoporphyria (EPP) is a rare hereditary disease that occurs worldwide, but there are regional differences in its epidemiology. The disease is caused by a partial deficiency of ferrochelatase, which is the last enzyme in the pathway of heme biosynthesis. In typical EPP, photosensitivity appears after first exposure to the sun in early childhood. Microcytic anemia is observed in 20-60% of registered EPP patients, which is mistakenly initially diagnosed as iron-deficiency anemia and prescribed iron-containing drugs. Purpose - is to present a clinical case of iron refractory hypochromic microcytic anemia in a four-month-old boy to improve the diagnosis of EPP. Clinical case. In the publication, we report on a 4-month-old boy in whom the disease debuted with hypochromic microcytic anemia refractory to the administration of iron preparations, target-like erythrocytes, normal indicators of iron metabolism, a slight enlargement of the spleen were found in the peripheral blood smear. The emphasis in the publication is on differential diagnosis, preventive measures and modern pathogenetic treatment with the latest approaches, which are aimed at solving the main defects at the molecular or cellular level, with the prospect of significantly improving the results of this orphan disease. Verification of the disease took place with the help of genome sequencing, a heterozygous pathogenic mutation FECH c.315-48T>C, characteristic of EPP which the child received from the father, was found. The experience of iron-refractory hypochromic microcytic anemia in a four-month-old boy gave grounds to expand the range of examinations, including hemoglobin electrophoresis and the use of molecular genetic studies, for differential diagnostic purposes. The report of this clinical case will be of informational value for family doctors, pediatricians, hematologists and a wide range of specialists. The research was carried out in accordance with the principles of the Helsinki Declaration. The informed consent of the patient was obtained for conducting the studies. No conflict of interests was declared by the authors.